Outcomes4Me Secures $21M in Funding Learn more >>

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.

Bone is the most common site for breast cancer to spread when it becomes metastatic....

Palliative care for metastatic breast cancer: What you need to knowPalliative care is a specialized...

Integrative oncology for breast cancer: Managing HER2 treatment side effectsIf you’ve been diagnosed with HER2-positive...

Recent advancements have brought attention to a specific group of breast cancers called “HER2-low.” These...

The power of exercise after HER2-positive breast cancerIf you’ve been diagnosed with HER2-positive breast cancer,...

From targeted therapies to managing side effects, this year’s American Society of Clinical Oncology (ASCO)...

Safety outcomes with first-line treatment of Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) plus Perjeta (pertuzumab) is comparable...

Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...

The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...

A recent study is aiming to understand and classify the HER2 protein levels in breast...

One of the most important first steps after receiving a breast cancer diagnosis is understanding...